Jpmorgan Chase & CO Qualigen Therapeutics Inc Com Transaction History

Jpmorgan Chase & CO

  • $1.14 Trillion
  • Q2 2024

A detailed history of Jpmorgan Chase & CO transactions in Qualigen Therapeutics Inc Com stock. As of the latest transaction made, Jpmorgan Chase & CO holds 252 shares of QLGNZZZZ stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
252
Previous 286 11.89%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
SELL
N/A
-34 Reduced 11.89%
252 $0
Q1 2024

May 10, 2024
SELL
N/A
-100 Reduced 25.91%
286 $0
Q4 2023

Feb 12, 2024
SELL
N/A
-1 Reduced 0.26%
386 $0
Q3 2023

Nov 14, 2023
BUY
N/A
2 Added 0.52%
387 $0
Q2 2023

Aug 11, 2023
BUY
N/A
385 New
385 $0

Others Institutions Holding QLGNZZZZ

# of Institutions
23
Shares Held
393K
Call Options Held
0
Put Options Held
0
View Full List

About QUALIGEN THERAPEUTICS INC COM

QLGNZZZZ Quotes by TradingView
  • Ticker QLGNZZZZ
More about QLGNZZZZ
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email